Akero Therapeutics Inc
AKRO
Market Cap$3.1B
Close$
$4.52
90.6% downside
Current Fair Value
90.6% downsideOvervalued by 90.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.10 Billion |
|---|---|
| Enterprise Value | $2.93 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.75 |
| Beta | -0.13 |
| Outstanding Shares | 78,656,629 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.35 |
|---|---|
| PEG | -13.62 |
| Price to Sales | - |
| Price to Book Ratio | 3.72 |
| Enterprise Value to Revenue | 10319.18 |
| Enterprise Value to EBIT | -10.88 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data